Biomarin Pharmaceutical Inc: Form 8-K, filed Feb 24, 2025

Filed with the SEC on Feb 24, 2025 and accepted by EDGAR at Feb 24, 2025, 16:30 ET.

Share this page

Link

X
Threads
Bluesky
LinkedIn
Facebook
Reddit
WhatsApp
Telegram
Pinterest
Hacker News
Email

Story card, 1080 × 1920

Items reported

Item 5.02 Departure or appointment of officers or directors

Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.

Source: SEC EDGAR, the filing index for accession 0001193125-25-033463. Last ingested by Listed: Nov 2, 2026, 16:49 ET. Listed shows no prices and gives no investment advice.